Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles
US6933387B2 · kind B2 · utility
1Cited by
2References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 25, 2003 |
| Grant date | Aug 23, 2005 |
| Priority date | — |
| Expiry date | Mar 25, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to 1,2,3,4,10,10a-hexahydropyrazino [1,2-a]indole derivatives of formula (I): as well as pharmaceutically acceptable salts, hydrates and esters thereof, wherein the substituents have the meanings provided in the specification. Compounds of the present invention may be used in the treatment or prevention of obesity or Type II diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.